CR Double-Crane Pharma's Nine Drugs Chosen in China's Centralized Drug Bid; Shares Down 3%

MT Newswires Live12-16

China Resources Double-Crane Pharmaceutical's (SHA:600062) nine drugs were selected for China's centralized drug procurement bid, according to a Shanghai Stock Exchange disclosure on Saturday.

The drugs are sugammadex sodium injection, mirabegron extended-release tablets, phloroglucinol injection, potassium chloride injection, roxatidine acetate hydrochloride for injection, sodium lactate ringer's injection, sodium bicarbonate ringer's injection, epalrestat tablets, and apremilast tablets.

The pharmaceutical company's amikacin sulfate injection, peramivir injection, and aminophylline injection also participated in the bidding but were not shortlisted.

The company's shares dropped less than 3% in recent trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2491636493?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-16 12:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2491636493","market":"fut","top_or_hot":-1,"title":"CR Double-Crane Pharma's Nine Drugs Chosen in China's Centralized Drug Bid; Shares Down 3%","media":"MT Newswires Live","content":"<html><body><p> China Resources Double-Crane Pharmaceutical's (SHA:600062) nine drugs were selected for China's centralized drug procurement bid, according to a Shanghai Stock Exchange disclosure on Saturday.</p><p>The drugs are sugammadex sodium injection, mirabegron extended-release tablets, phloroglucinol injection, potassium chloride injection, roxatidine acetate hydrochloride for injection, sodium lactate ringer's injection, sodium bicarbonate ringer's injection, epalrestat tablets, and apremilast tablets.</p><p>The pharmaceutical company's amikacin sulfate injection, peramivir injection, and aminophylline injection also participated in the bidding but were not shortlisted.</p><p>The company's shares dropped less than 3% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR Double-Crane Pharma's Nine Drugs Chosen in China's Centralized Drug Bid; Shares Down 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR Double-Crane Pharma's Nine Drugs Chosen in China's Centralized Drug Bid; Shares Down 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-16 12:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>China Resources Double-Crane Pharmaceutical's (SHA:600062) nine drugs were selected for China's centralized drug procurement bid, according to a Shanghai Stock Exchange disclosure on Saturday.The ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2491636493","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2491636493","pubTimestamp":1734325129,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Double-Crane Pharmaceutical's  nine drugs were selected for China's centralized drug procurement bid, according to a Shanghai Stock Exchange disclosure on Saturday.The drugs are sugammadex sodium injection, mirabegron extended-release tablets, phloroglucinol injection, potassium chloride injection, roxatidine acetate hydrochloride for injection, sodium lactate ringer's injection, sodium bicarbonate ringer's injection, epalrestat tablets, and apremilast tablets.The pharmaceutical company's amikacin sulfate injection, peramivir injection, and aminophylline injection also participated in the bidding but were not shortlisted.The company's shares dropped less than 3% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600062":"华润双鹤","BK0239":"医药制造","BK0185":"二线龙头","CR":"crane","BK0175":"白马股","BK0188":"融资融券","BK0010":"央企","BK0028":"国家队","BK4161":"工业机械"},"translate_title":"华润双鹤药业9个药品入选中国药品集中招标；股价下跌3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600062":0.9,"CR":1},"content_text":"China Resources Double-Crane Pharmaceutical's (SHA:600062) nine drugs were selected for China's centralized drug procurement bid, according to a Shanghai Stock Exchange disclosure on Saturday.The drugs are sugammadex sodium injection, mirabegron extended-release tablets, phloroglucinol injection, potassium chloride injection, roxatidine acetate hydrochloride for injection, sodium lactate ringer's injection, sodium bicarbonate ringer's injection, epalrestat tablets, and apremilast tablets.The pharmaceutical company's amikacin sulfate injection, peramivir injection, and aminophylline injection also participated in the bidding but were not shortlisted.The company's shares dropped less than 3% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491636493"}